Paclitaxel plus doxorubicin in breast cancer: An italian experience

Seminars in Oncology

Volumn 24, Issue 5 SUPPL. 17, 1997, Pages

  Frassineti, G L ^a   Zoli, W ^a   Silvestro, L ^a   Serra, P ^a   Milandri, C ^a   Tienghi, A ^a   Gianni, L ^a   Gentile, A ^a   Salzano, E ^a   Amadori, D ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTHRALGIA; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ITALY; MUCOSA INFLAMMATION; MYALGIA; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING; ARTICLE; BREAST TUMOR; DISEASE FREE SURVIVAL; DOSE RESPONSE; MIDDLE AGED;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL;

EID: 0031254775     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)